Creation of a Database of Images of the Eye with the Holographic Doppler Laser
Launched by FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD · Oct 14, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on using a new device called the holographic Doppler laser to take detailed images of the blood vessels in the eye. By studying these images, researchers hope to better understand various eye conditions that are related to blood flow problems, which can help in making accurate diagnoses. The trial is currently recruiting participants who are 18 years or older, and it includes those with specific eye conditions, such as glaucoma or diabetic retinopathy, as well as individuals without any known eye problems.
Participants in this study will have the opportunity to contribute to important research while experiencing minimal risks. They will need to provide informed consent, meaning they understand the study and agree to take part. Those who participate will undergo eye examinations using the new device to capture images and videos of their eye's blood vessels. It’s important to note that there are certain criteria that would exclude someone from participating, such as having specific medical devices or conditions that could be affected by the imaging process. This trial aims to improve our understanding of eye health and could lead to better treatments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- For all participants:
- • Age ≥ 18 years
- • Having received informed information about the study and having signed a consent to participate in the study
- • Affiliated or beneficiary of social insurance
- For participants with no known ocular pathology:
- • - No known ocular pathology other than a refractive disorder
- For patients with optic nerve pathology:
- • - Patient undergoing ophthalmology consultation for optic nerve pathology in at least one eye (examples: glaucoma, optic neuritis, hereditary optic nerve diseases)
- For patients with retinal and/or choroidal pathology:
- • - Patients undergoing ophthalmology consultations for retinal and/or choroidal pathology in at least one eye (examples: diabetic retinopathy, age-related macular degeneration).
- For patients with retinal vascular pathology:
- • - Patient undergoing ophthalmology consultation for retinal vascular pathology in at least one eye (e.g. central retinal artery occlusion, central retinal vein occlusion, ocular ischemia syndrome).
- Exclusion Criteria:
- • Inability to maintain a stable sitting position
- * Contraindications to holographic doppler laser :
- • implanted medical electronic device (pacemaker or other)
- • history of photosensitivity.
- • received photo-dynamic therapy (PDT) within the last 3 months.
- • viral conjunctivitis or any other infectious disease.
- • skin lesions on the neck or forehead, not allowing contact with a chin strap
- • patients at high risk of damage from optical radiation (e.g. aphakic patients, or patients with reduced sensitivity to light due to disease of the back of the eye).
About Fondation Ophtalmologique Adolphe De Rothschild
The Fondation Ophtalmologique Adolphe de Rothschild is a leading French institution dedicated to advancing ophthalmic research and patient care. Renowned for its commitment to innovation in eye health, the foundation conducts cutting-edge clinical trials aimed at improving treatments for various ocular conditions. With a multidisciplinary team of experts, the foundation collaborates with academic and industry partners to enhance understanding of eye diseases and develop novel therapeutic solutions, ultimately striving to improve patient outcomes and quality of life in ophthalmology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported